Skip Navigation
Search site

We are building you a better website. You might be interested to see the new look here, and let us know what you think.

Hospital Prescribing, England - 2012

07:12 May 27, 2017 - 09:30 November 13, 2013
Publication date: November 13, 2013
Return to Find data


Please note: on 26 November 2013 an updated version of the report was uploaded to correct an error in the data presented for England in Table 3 of the report. All SHA figures in this table were correct and remain the same. This was due to a production error by the HSCIC.

This report compares expenditure between primary and secondary care in total and for selected areas, including medicines positively appraised by NICE. The specific area covered this year are anti-bacterial drugs (BNF Section 5.1).

Key facts

  • The overall NHS expenditure on medicines in 2012 was £13.3 billion.
  • In 2012 hospital use accounted for 36.5 per cent of the total cost, up from 33.3 per cent in 2011.
  • The cost of medicines rose by 1.5 per cent overall but by 11.1 per cent in hospitals.
  • Of the drugs positively appraised by NICE, the greatest overall cost was for adalimumab, which also incurred the greatest cost in hospitals. 



Date Range: January 01, 2012 to December 31, 2012
Geographical coverage:
Geographical granularity:
Strategic Health Authorities

Related links

Return to Find data
Close iCM Form